Metabolic Profiling in Human Fibroblasts Enables Subtype Clustering in Glycogen Storage Disease.
energy deficiency
glycogen storage disease
inborn error of metabolism
metabolism
metabolomics
mitochondria
redox homeostasis
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2020
2020
Historique:
received:
03
07
2020
accepted:
21
10
2020
entrez:
17
12
2020
pubmed:
18
12
2020
medline:
4
6
2021
Statut:
epublish
Résumé
Glycogen storage disease subtypes I and III (GSD I and GSD III) are monogenic inherited disorders of metabolism that disrupt glycogen metabolism. Unavailability of glucose in GSD I and induction of gluconeogenesis in GSD III modify energy sources and possibly, mitochondrial function. Abnormal mitochondrial structure and function were described in mice with GSD Ia, yet significantly less research is available in human cells and ketotic forms of the disease. We hypothesized that impaired glycogen storage results in distinct metabolic phenotypes in the extra- and intracellular compartments that may contribute to pathogenesis. Herein, we examined mitochondrial organization in live cells by spinning-disk confocal microscopy and profiled extra- and intracellular metabolites by targeted LC-MS/MS in cultured fibroblasts from healthy controls and from patients with GSD Ia, GSD Ib, and GSD III. Results from live imaging revealed that mitochondrial content and network morphology of GSD cells are comparable to that of healthy controls. Likewise, healthy controls and GSD cells exhibited comparable basal oxygen consumption rates. Targeted metabolomics followed by principal component analysis (PCA) and hierarchical clustering (HC) uncovered metabolically distinct poises of healthy controls and GSD subtypes. Assessment of individual metabolites recapitulated dysfunctional energy production (glycolysis, Krebs cycle, succinate), reduced creatinine export in GSD Ia and GSD III, and reduced antioxidant defense of the cysteine and glutathione systems. Our study serves as proof-of-concept that extra- and intracellular metabolite profiles distinguish glycogen storage disease subtypes from healthy controls. We posit that metabolite profiles provide hints to disease mechanisms as well as to nutritional and pharmacological elements that may optimize current treatment strategies.
Identifiants
pubmed: 33329388
doi: 10.3389/fendo.2020.579981
pmc: PMC7719825
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
579981Informations de copyright
Copyright © 2020 Hannibal, Theimer, Wingert, Klotz, Bierschenk, Nitschke, Spiekerkoetter and Grünert.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Pediatr. 1980 Dec;97(6):906-10
pubmed: 6255119
PLoS Biol. 2010 Oct 19;8(10):e1000514
pubmed: 21049082
Comput Struct Biotechnol J. 2013 Mar 22;4:e201301009
pubmed: 24688690
J Clin Invest. 1995 Jan;95(1):234-40
pubmed: 7814621
Vestn Ross Akad Med Nauk. 2014;(7-8):78-84
pubmed: 25563007
N Engl J Med. 1968 Oct 31;279(18):965-70
pubmed: 4300573
J Biol Chem. 1980 Sep 25;255(18):8381-4
pubmed: 6251055
Bone. 2016 May;86:79-85
pubmed: 26924264
Sci Rep. 2017 Mar 20;7:44408
pubmed: 28317891
J Biol Chem. 1952 Dec;199(2):661-7
pubmed: 13022673
Curr Metabolomics. 2013;1(1):92-107
pubmed: 26078916
Metabolites. 2019 Oct 18;9(10):
pubmed: 31635306
J Inherit Metab Dis. 2018 May 8;:
pubmed: 29740774
Science. 1993 Oct 22;262(5133):580-3
pubmed: 8211187
J Hepatol. 2018 Nov;69(5):1074-1087
pubmed: 30193922
Eur J Biochem. 1967 Oct;2(3):265-70
pubmed: 5235982
Orphanet J Rare Dis. 2020 Aug 24;15(1):218
pubmed: 32838757
Mol Genet Metab. 2011 Jul;103(3):226-39
pubmed: 21497120
J Endocrinol. 2018 Sep;238(3):R131-R141
pubmed: 29875163
Hum Mutat. 1997;9(1):37-40
pubmed: 8990006
Hum Mol Genet. 2016 Sep 1;25(17):3784-3797
pubmed: 27436577
J UOEH. 1990 Dec 1;12(4):411-8
pubmed: 2287841
Curr Opin Clin Nutr Metab Care. 2015 Jul;18(4):415-21
pubmed: 26001652
Nucleic Acids Res. 2018 Jan 4;46(D1):D608-D617
pubmed: 29140435
J Clin Invest. 1996 Jul 15;98(2):352-7
pubmed: 8755644
FEBS J. 2020 Dec;287(23):5096-5113
pubmed: 32160399
Genet Med. 2010 Jul;12(7):446-63
pubmed: 20631546
Diabetologia. 2009 Aug;52(8):1689-90; author reply 1691-2
pubmed: 19440688
Diabetologia. 2009 May;52(5):952-61
pubmed: 19263033
Perspect Pediatr Pathol. 1979;5:237-62
pubmed: 537860
J Inherit Metab Dis. 2018 Nov;41(6):985-995
pubmed: 29435782
J Hum Genet. 2006;51(11):958-963
pubmed: 17047887
J Inherit Metab Dis. 2018 Nov;41(6):955-963
pubmed: 29869165
J Pediatr. 1990 Jan;116(1):95-100
pubmed: 2295969